Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
15(19)-tetraen-3-ol
InChiKey: BFUUJUGQJUTPAF-UHFFFAOYSA-N
significantly suppresses constitutively activated Akt and MAP kinase
Bosutinib received US FDA and EU European Medicines Agency approval on September 4
and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors
Anidulafungin - CAS# 166663-25-8 anfacine Hydrochloride 15(19)-tetraen-3-olAnidulafungin, also known as LY303366, is a semisynthetic echinocandin used as an antifungal drug. Anidulafungin was approved on 2 21 2006. Anidulafungin has proven efficacy against esophageal candidiasis, but its main use will probably be in invasive Candida infection; it may also have application in treating invasive Aspergillus infection. It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by
US$ 56.95
US$ 39.00
US$ 14.00
US$ 149.95